Skip to main content
  1. Right Decisions
  2. DGRefHelp - NHS Dumfries & Galloway
  3. Sexual health
  4. Sexually transmitted infections (STIs)
  5. Back
  6. Syphilis
  7. Late Latent Syphilis
Important: please update your RDS app to version 4.7.3 Details with newsletter below.

Please update your RDS app to v4.7.3

We asked you in January to update to v4.7.2.  After the deployment planned for 27th February, this new update will be needed to ensure that you are able to download RDS toolkits even when the RDS website is not available. We will wait until as many users as possible have downloaded the new version before switching off the old system for app downloads and moving entirely to the new approach.

To check your current RDS version, click on the three dots bottom right of the RDS app screen. This takes you to a “More” page where you will see the version number. 

To update to the latest release:

 On iPhones – go to the Apple store, click on your profile icon top right, scroll down to see the apps waiting to be updated and update the RDS app.

On Android phones – these can vary, but try going to the Google Play store, click on your profile icon top right, click on “Manage apps and device”, select and update the RDS app.

Right Decision Service newsletter: February 2025

Welcome to the February 2025 update from the RDS team

1.     Next release of RDS

 

A new release of RDS is planned (subject to outcomes of current testing) for week beginning 24th February. This will deliver:

 

  • Fixes to mitigate the recurring glitches with the RDS admin area and the occasional brief user interface outages which have arisen following implementation of the new distributed technology infrastructure in December 2024.

 

  • Capability to embed content from Google calendar, Google Maps, Daily Motion, Twitter feeds, Microsoft Stream into RDS pages.

 

  • Capability to include simple multiplication in RDS calculators.

 

The release will also incorporate a number of small fixes, including:

  • Exporting of form within Medicines Sick Day Guidance in polypharmacy toolkit
  • Links to redundant content appearing in search in some RDS toolkits
  • Inclusion of accordion headers alongside accordion text in search result snippets.
  • Feedback form on mobile app.
  • Internal links on mobile app version of benzo tapering tool

 

We will let you know when the date and time for the new release are confirmed.

 

2.     New RDS developments

There is now the capability to publish toolkits on the web with left hand side navigation rather than tiles on the homepage. To use this feature, turn on the “Toggle navigation panel” option at the top of the Page settings menu at toolkit homepage level – see below. Please note that publication to downloadable mobile app for this type of navigation is still under development.

The Benzodiazepine tapering tool is now available as part of the RDS toolkit for the national benzodiazepine prescribing guidance developed by the Scottish Government Effective Prescribing team. The tool uses this national guidance developed with a wide-ranging multidisciplinary group. This should be used in combination with professional judgement and an understanding of the needs of the individual patient.

3.     Archiving and version control and new RDS Search and Browse interface

Due to the intensive work Tactuum has had to undertake on the new technology infrastructure has pushed back the delivery dates again and some new requirements have come out of the recent user acceptance testing. It now looks likely to be an April release for the search and browse interface. The archiving and version control functionality may be released earlier. We’ll keep you posted.

4.     Statistics

At the end of January, Olivia completed the generation of the latest set of usage statistics for all RDS toolkits. If you would like a copy of the stats for your toolkit, please contact Olivia.graham@nhs.scot .

 

5.     Review of content past its review date

We have now generated reports of all RDS toolkit content that has exceeded its review date by 6 months or more. We will be in touch later this month with toolkit owners and editors to agree the plan for updating or withdrawing out of date content.

 

6.     Toolkits in development

Some important toolkits in development by the RDS team include:

  • National CVD prevention pathways – due for release end of March 2025.
  • National respiratory pathways, optimal cancer diagnostic pathways and cancer prehabilitation pathways from the Centre for Sustainable Delivery. We will shortly start work on the national cancer referral pathways, first version due for release via RDS around end of June 2025.
  • HIS Quality of Care Review toolkit – currently in final stages of quality assurance.

 

The RDS team and other information scientists in HIS have also been producing evidence summaries for the Scottish Government Realistic Medicine team, to inform development of national guidance around Procedures of Limited Clinical Value. This guidance will in due course be translated into an RDS toolkit.

 

7. Training sessions for new editors (also serve as refresher sessions for existing editors) will take place on the following dates:

  • Friday 28th February 12-1 pm
  • Tuesday 11th March 4-5 pm

 

To book a place, please contact Olivia.graham@nhs.scot, providing your name, organisation, job role, and level of experience with RDS editing (none, a little, moderate, extensive.)

 

To invite colleagues to sign up to receive this newsletter, please signpost them to the registration form  - also available in End-user and Provider sections of the RDS Learning and Support area.   If you have any questions about the content of this newsletter, please contact his.decisionsupport@nhs.scot  If you would prefer not to receive future newsletters, please email Olivia.graham@nhs.scot and ask to be removed from the circulation list.

With kind regards

 

Right Decision Service team

Healthcare Improvement Scotland

 

 

Late Latent Syphilis

Warning

Incubation, Examination

Syphilis serology is positive, patient is asymptomatic and has no known negative serology within the last 2 years.

See below for investigations required.

Examination

  • All patients need a careful clinical cardiovascular and neurological history recorded in the notes.
  • Auscultation must be performed in patients with late latent or tertiary syphilis.
  • Patients who have signs or symptoms of cardiovascular involvement should have a full cardiovascular assessment. Consider an echocardiogram +/- chest x-ray before starting therapy to exclude aortic valve disease. Patients with clinical or radiological evidence of aortic valve disease must be referred to a cardiologist for further assessment.
  • Patients should have a thorough neurological examination if they have symptoms suggestive of neurological involvement
  • The BASHH 2015 guidelines discuss the necessity of CSF examination in asymptomatic patients. Asymptomatic patients with no clinical findings consistent with neuro-syphilis do not need a lumber puncture. CSF examination should be done in those who have:
    • Neurological/opthalmological signs/symptoms
    • VDRL/RPR 1:32 or greater
    • Those with treatment failure

Treatment

There is much less urgency in treating late syphilis and it is better to plan treatment so that it can be reliably completed

 

**Benzathine penicillin G 2.4 MU intramuscular on day 1 & 8 & 15
(as Extencilline 8ml) (NB unlicensed medication, named patient form may be needed)
For administration, see Preparation Instructions for Extencilline 2.4MU
OR
**Procaine penicillin 600,000units intramuscular once daily for 14 days
(**unlicensed medications, named patient form may be needed)
PENICILLIN ALLERGIC (or declines parenteral):
Doxycycline 100mg twice daily orally for 28 days

Complications

  • Jarisch Herxheimer reaction is less common than in early syphilis
  • Procaine reaction. This is caused by inadvertent IV injection of procaine penicillin which is minimised by the aspiration technique of injection. Lasts for less than 20 minutes and is characterised by feelings of impending death +/- seizures. Anaphylaxis should be excluded and the patient should be reassured and calmed. Sedation may be required for seizures.
  • Anaphylaxis – facilities for resuscitation must be present. Refer to local policy for further guidance

Patients should remain on the premises for 15 minutes after receiving their 1st injection to allow observation for immediate adverse reactions.

Partner Notification and Follow -Up

Partner Notification 

  • All patients to see sexual health adviser

Follow-up

  • 4 weeks after end of treatment regime - to check compliance and partner notification
  • 3 months - to repeat serology ± HIV test
  • VDRL/RPR is often negative in late syphilis but this does not exclude the need for treatment. Follow up is to ensure adherence and for completion of partner notification. Discharge at 3 months if VDRL/RPR remains negative.
  • If VDRL/RPR titre was raised prior to treatment, repeat at 3,6,12 months until VDRL/RPR negative or reduced and serologically stable on two occasions.
  • Ask permission to write to GP to confirm treatment complete, give patient a written summary of treatment with discharge serology 

Editorial Information

Last reviewed: 30/09/2022

Next review date: 30/09/2024

Author(s): West of Scotland Managed Clinical Network in Sexual Health Clinical Guidelines Group .

Version: 7.1

Approved By: West of Scotland Managed Clinical Network in Sexual Health